BioAtla (BCAB) Interest Coverage Ratio (QoQ) (2020 - 2025)
BioAtla (BCAB) Interest Coverage Ratio (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -258.52% |
| Jun 30, 2025 | 96.12% |
| Mar 31, 2025 | 98.12% |
| Dec 31, 2024 | -36,510.26% |
| Sep 30, 2024 | 31.58% |
| Jun 30, 2024 | -23,746.13% |
| Mar 31, 2024 | 99.95% |
| Dec 31, 2023 | -151.29% |
| Sep 30, 2023 | -10,845.77% |
| Jun 30, 2023 | 99.47% |
| Mar 31, 2023 | 0.45% |
| Dec 31, 2022 | -745,481.12% |
| Sep 30, 2022 | 97.95% |
| Jun 30, 2022 | 99.28% |
| Mar 31, 2022 | -2.00% |
| Dec 31, 2021 | 1.14% |
| Sep 30, 2021 | -3,095.51% |
| Jun 30, 2021 | 96.63% |
| Mar 31, 2021 | -116.99% |
| Dec 31, 2020 | 475.66% |